Skip to main content
. Author manuscript; available in PMC: 2015 Nov 9.
Published in final edited form as: Leukemia. 2014 Dec 26;29(5):1218–1221. doi: 10.1038/leu.2014.348

Figure 2.

Figure 2

(a) Waterfall plot of proteins significantly associated with MET phosphorylation. (b) Dose–response surface of ligand-dependent MET kinase activation by HGF and competitive kinase inhibition by crizotinib. Blue-to-red color gradient indicates MET kinase activation. Black dots represent crizotinib plasma trough concentrations achievable in patients.